Janssen Vaccines & Prevention B.v.

This study was the first to test a new 'universal' flu vaccine candidate in people. The main goal was to check if the vaccine was safe and caused acceptable side effects in 170 healthy adults. Researchers also measured if the vaccine triggered an immune response that could protec…

This large, completed Phase 3 study tested whether a new vaccine could prevent serious lower respiratory tract disease caused by RSV in adults aged 60 and older. Over 25,000 participants were randomly assigned to receive either the experimental vaccine or a placebo shot. The main…